# A Study Evaluating 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) In Healthy Infants In China

> **NCT01692886** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 1674 (actual)

## Conditions studied

- Pneumococcal Infection

## Interventions

- **BIOLOGICAL:** 7-valent Pneumococcal Conjugate Vaccine
- **BIOLOGICAL:** 13-valent Pnumococcal Conjugate vaccine
- **BIOLOGICAL:** 13-valent Pnumococcal Conjugate vaccine
- **BIOLOGICAL:** 13-valent Pnumococcal Conjugate vaccine

## Key facts

- **NCT ID:** NCT01692886
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 1674 (ACTUAL)
- **Last updated:** 2014-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01692886

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01692886, "A Study Evaluating 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) In Healthy Infants In China". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01692886. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*